Here is Josh's responses(in ")to your concerns;
Quote 1;
Buy-back with what?--Alper reported-->>$15,756<<--in cash and equivalents in his last disclosure. That would buy a mere 26 million shares today with nothing left over. Since then he has jetted off California, Israel, with Las Vegas and elsewhere still to come. BLDV apparently still operates out of his tiny condo in Chicago.
"The buy back is included in the use of funds for the Reg A+,"
Quote;
And speaking of the last disclosure-- on page 4 it states BLDV
issued 700 million "restricted" common shares for 25 percent of Cann10-NA. However, on page 11 it says nothing about those shares being restricted. So which is it? If Cann10 Israel isn't restricted from selling shares that might explain this nearly year long MOU to a merger nonsense.
"700 Million Shares are restricted for minimum 2 years from date of issue ( Jan 1, 2018 )"
Quote 2;
Well my guess would be, you have a couple multi billionaire coal guys and you have several Israeli Cannabis millionaire guys, if they believe in the company plan they can buy a chit load.
"We are building the business model of Israeli technology and innovation, and have strong support for the pan."
Quote;
Additionally to help reassure guys, I saw a filing/list of all who hold BLDV shares, the top guys/companies in BLDV all have shares, surprisingly not that huge amount so I gather they believe the shares are worth a lot of than current value or they'd have more) I'm thinking, they think we ought to be in pennies (or dimes) from the amounts they own
"No affiliate of BLDV insider has ever converted certificates or sold any share in any capacity, we don't believe that the purpose of the Public Company is to line the pockets of the C-Staff. We earn all the stock that is issued to principals, I currently own 110 Million Shares in my name, and have never bought or sold a single share."
Quote 3;
I don't quite understand, do you think BLDV is good or NOT?
Tired of tuning in every morning for about 10 years to seeing red...ready for a miracle!
"We started turning this around in April 2017, so under my watch it is only one and half years of activity."
Quote 4;
If Cann10 and Panaxia could get their sight set on world-wide and form a BLDV MPX merger - Now that'd be nice and it would further their Israel IP.
BLDVs got 1 contract inta state that soon-to-hav two-dozen others.
"Fully Agree"
Quote 5;
If there's co's doing trials for fda ongoing clearance hopes, panaxia be makn it.... right!
so Israel done here - it's only got get better to make us money.
better by effectuating healing i'll get some info how many's trialing
and which indications canereet treat ; since we gona hav a build a processor to make it.
mpx / 14mm
"The actual process is licensing, the export form Israel will be into less sophisticated markets and truly special formulation in small quantities. Each potential license holder receives the support for Israel & Cann10 North America, pays fees and royalties, and then gets access to the Cann10 XL an important part of the puzzle that does not get attention."
Quote 6;
Rather than a share buy-back...hire a lawyer and get that YIELD warning removed by having him produce the required annual attorney opinion letter. Problem is Josh may have blown that option by switching the calendar year to end on June 30th. I'm no expert but that may mean that such a letter can only be filed after a fiscal year has been completed. FY 2017 ended Dec 31st. FY 2018 ended 2 months later on June 30th, correct? So I guess we're 4 months into FY 2019 now which will end next June.
IMO moving the fiscal year to end in June was as bone headed as his telling OTC to report ClearTrust as the new transfer agent when Island Transfer had over 6 months left on their contract, That resulted in OTC reporting BLDV had zero market cap and zero sgares outstanding for months. It took months of haranging to get him to fix that screw up.
Meanwhile, the first thing prospective new investors see is a YIELD sign and a bloated, virtually maxed out O/S. Not a good first impression.
"In principle I agree with your comments, the change of year end was directed toward SEC reporting as we need one full year, by changing date we save 6 months. The Transfer Agent was a mistake, we did not know about the contract signed by John Moaning 5 years ago, The thing that will fix BLDV is real revenue and shared governance. These are the top priority for the company, as soon as we understand the final configuration with Cann10 we will focus on the Yield sign."
Quote 7;
Respectfully, IMO I think Josh can walk and chew gum at the same time. Addressing revenue along with coming up with ideas to reduce the number of outstanding shares seems reasonable to me. The cash to buy the shares could be secured from CANN and/or private investment. Given how cheap the price is you can buy a billion or two for virtually nothing, at least nothing to those that have deep pockets.
It’s Josh’s job to prove the shares are currently undervalued. If they’re not than we’re stuck where we are for a very long time. If it is undervalued as that radio guy who interviewed Josh thinks it is, then it would seem to be a win-win to buy back the shares ASAP. If price goes up than Josh will be a genius and we’ll finally see our patience rewarded.
I’m just trying to think out of the box. If there are other suggestions I’m all ears.
"I fully agree with your comments, revenue is king with a company that has made promises for years before I got here."
